GeneDx (NASDAQ:WGS), a genomic insights company ... The company has enhanced its laboratory processes for more efficient sequencing, analysis, and interpretation of genomic data.

We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against other best ...

GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey “Our list of the Most Innovative ...

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and ...

GAITHERSBURG, Md., March 13, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision ...

GAITHERSBURG, Md., March 04, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its ...

Reports FY24 revenue $305.5M, consensus $290.82M .”The fourth quarter capped an outstanding year for GeneDx (WGS), as we work to end the diagnostic odyssey with earlier intervention using our ...

Charles Schwab Investment Management Inc. increased its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report ...

Shares of GeneDx Holdings shot up 24% following higher-than-expected revenue in its fourth quarter. Shares were trading around $95. Over the last year, the stock is up nearly 1800%. The patient ...